Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04836416 · ClinicalTrials.gov registry record

Appetite Variability

A clinical trial, sponsored by Purdue University.

Completed
Registry status
109
Enrollment target

NCT04836416: Completed study, sponsored by Purdue University.

NCT04836416 is a clinical trial that has completed, run by Purdue University. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04836416 has completed, sponsored by Purdue University.

COMPLETED
Registry status
109 participants
Enrollment target

Study Summary

This study will examine appetitive sensation variability and the relationship between appetitive sensations and energy intake. Investigators believe the methods for assessing and interpretation of appetitive sensations are problematic and mask the true influence of these sensations on eating. This limits the development of guidelines for weight management. To gain a better understanding of the relationship, investigators will track hourly appetite sensations and map these to eating events via time-series analyses to gain new insights on the directionality and magnitude of these relationships. Also, investigators will also examine the association of apetitive ratings with age or gender. This will allow the development of more effective weight management recommendations.

Primary Outcome

A positive association between hunger and eating frequency.

Interventions

  • OTHER Observational

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2021-04-02
Est. Completion 2022-12-31
Purdue University

141 total trials

What the finished NCT04836416 record still lists

NCT04836416 is an observational study that tracks outcomes without assigning an intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.

NCT04836416 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04836416 about?

NCT04836416 is a clinical study titled "Appetite Variability". This study will examine appetitive sensation variability and the relationship between appetitive sensations and energy intake. Investigators believe the methods for assessing and interpretation of appetitive sensations are problematic and mask the true influence of these sensations on eating. This l...

What is the current status of trial NCT04836416?

This trial is currently completed. The enrollment target is 109 participants. The study started on 2021-04-02. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT04836416?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT04836416?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04836416, the US trial registry maintained by the National Library of Medicine. NCT04836416 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.